Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015)
Scynexis (SCYX) posted Liabilities from Discontinued Operations of 2099000.0 for Q2 2015, down 13.26% on a QoQ basis from 2420000.0 in Q4 2014.
Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015) Analysis & Trends
Scynexis' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 2099000.0 for Q2 2015.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 2099000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was 2099000.0 (changed N/A YoY) and the FY2014 annual result came in at 2420000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was 2099000.0 for Q2 2015 at Scynexis, down from 2420000.0 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 2420000.0 in Q4 2014 and bottomed at 2099000.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2.10 Mn |
| Jun 30, 2015 | 2.10 Mn |
| Dec 31, 2014 | 2.42 Mn |
| Dec 31, 2014 | 2.42 Mn |